Search results
Jump to navigation
Jump to search
- chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time2 statements, 0 sitelinks - 22:27, 7 January 2024
- ...[metabolize]]d and/or excreted. For example, the "fraction bound" of the [[anticoagulant]] [[warfarin]] is 97%. This means that out of the amount of warfarin in the ...ein, thus increasing the concentration of free warfarin and increasing its anticoagulant effect. However, the real problem is that phenylbutazone interferes with th ...8 KB (1,201 words) - 12:11, 15 November 2023
- * [[Anticoagulant/ja|抗凝固剤]] ...9 KB (422 words) - 17:29, 25 March 2024
- * [[Anticoagulant]] ...7 KB (907 words) - 10:49, 25 March 2024
- * [[Anticoagulant]] ...7 KB (941 words) - 10:47, 25 March 2024
- 一部の[[anticoagulant/ja|抗凝固薬]]、特に[[warfarin/ja|ワルファリン]]は、[[vitamin K/ja|ビタミンK]]の代謝を阻害することによって血栓形 ...54 KB (1,314 words) - 18:46, 7 March 2024
- ...e compound is less toxic to non-target species than earlier generations of anticoagulant rodenticides ([[Warfarin]] and [[Congener (chemistry)|congeners]]) or [[Bro ...18 KB (2,635 words) - 21:30, 11 April 2024
- ...e compound is less toxic to non-target species than earlier generations of anticoagulant rodenticides ([[Warfarin]] and [[Congener (chemistry)|congeners]]) or [[Bro ...18 KB (2,713 words) - 21:28, 11 April 2024
- ...may cause [[hematoma]] and bruising around the injection site due to their anticoagulant effect. This includes [[heparin]] and [[low molecular weight heparin]] prod ...22 KB (2,885 words) - 17:22, 3 January 2023
- ...er [[cholesterol]] such as [[statin]]s, [[blood pressure medication]], and anticoagulant therapies to reduce the risk of blood clot formation. As the disease state There is evidence that some [[anticoagulant]]s, particularly [[warfarin]], which inhibit clot formation by interfering ...44 KB (6,247 words) - 22:10, 5 March 2024
- ...er [[cholesterol]] such as [[statin]]s, [[blood pressure medication]], and anticoagulant therapies to reduce the risk of blood clot formation. As the disease state There is evidence that some [[anticoagulant]]s, particularly [[warfarin]], which inhibit clot formation by interfering ...45 KB (6,411 words) - 22:09, 5 March 2024
- * [[Coagulation|凝固]]: [[anticoagulant/ja|坑凝固薬]]、[[heparin/ja|ヘパリン]]、[[antiplatelet drug/ja|坑血小板薬]]、[[Fibrinolysis ...58 KB (1,845 words) - 17:09, 5 November 2023
- * [[Coagulation|Coagulation]]: [[anticoagulant|anticoagulant]]s, [[heparin|heparin]], [[antiplatelet drug|antiplatelet drug]]s, [[Fibrin ...52 KB (6,923 words) - 17:09, 5 November 2023
- * [[Coagulation|Coagulation]]: [[anticoagulant|anticoagulant]]s, [[heparin|heparin]], [[antiplatelet drug|antiplatelet drug]]s, [[Fibrin ...54 KB (7,245 words) - 17:08, 5 November 2023
- ...rom such an animal, a [[goat]], was approved. The drug, [[ATryn]], is an [[anticoagulant]] which reduces the probability of [[blood clot]]s during [[surgery]] or [[ ...217 KB (29,051 words) - 07:55, 4 January 2023